Q2 2025 · 13F-HR
Rangeley Capital, LLCholdings as filed
Filed 2025-08-14 · accession 0000919574-25-004826
$83.8M
Reported value
73
Positions
2025-06-30
Period end
The Brief · Rangeley Capital, LLC · Q2 2025
AI · grounded in 13F
Rangeley Capital, LLC established a new position in Sage Therapeutics Inc SG7 valued at $6.66M. The fund also initiated stakes in Delek US Hldgs Inc New DK for $6.63M and Arvinas Inc ARVN for $5.11M. Additional new positions include Calumet Inc CLMT at $5.03M and Prothena Corp PLC at $4.34M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $6.7M | 7.94% | 730,000 | Common | SOLE |
| 24665A103 | DK | DELEK US HLDGS INC NEW | $6.6M | 7.91% | 313,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $5.1M | 6.10% | 694,800 | Common | SOLE |
| 131428104 | CLMT | CALUMET INC | $5.0M | 6.00% | 319,000 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $4.3M | 5.18% | 715,367 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $3.8M | 4.55% | 285,400 | Common | SOLE |
| 86881A100 | SGRY | SURGERY PARTNERS INC | $3.7M | 4.40% | 166,060 | Common | SOLE |
| 16119P108 | CHTR | CHARTER COMMUNICATIONS INC N | $3.7M | 4.39% | 9,000 | CALL | SOLE |
| 96758W101 | WOW | WIDEOPENWEST INC | $3.2M | 3.87% | 799,000 | Common | SOLE |
| 359678109 | FLL | FULL HSE RESORTS INC | $3.2M | 3.85% | 882,426 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $3.0M | 3.59% | 302,080 | Common | SOLE |
| 812215200 | SEG | SEAPORT ENTMT GROUP INC | $2.9M | 3.52% | 158,000 | Common | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $2.7M | 3.19% | 865,000 | Common | SOLE |
| 21874A114 | CORZW | CORE SCIENTIFIC INC NEW | $2.5M | 2.98% | 146,200 | Common | SOLE |
| 64110Y108 | NLOP | NET LEASE OFFICE PROPERTIES | $2.3M | 2.72% | 70,000 | Common | SOLE |
| 830566105 | SKAA | SKECHERS U S A INC | $2.3M | 2.71% | 36,000 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $1.6M | 1.88% | 290,000 | Common | SOLE |
| 127537207 | CDZI | CADIZ INC | $1.4M | 1.67% | 469,000 | Common | SOLE |
| 85512G106 | STHO | STAR HLDGS | $1.3M | 1.60% | 172,000 | Common | SOLE |
| 126633205 | UAN | CVR PARTNERS LP | $1.3M | 1.59% | 15,000 | Common | SOLE |
| 371927104 | GEL | GENESIS ENERGY L P | $1.3M | 1.52% | 74,000 | Common | SOLE |
| 931427108 | WFC | WALGREENS BOOTS ALLIANCE INC | $1.2M | 1.40% | 102,000 | Common | SOLE |
| 63900P608 | NRP | NATURAL RESOURCE PARTNERS L | $1.2M | 1.38% | 12,100 | Common | SOLE |
| 03212B103 | AMPY | AMPLIFY ENERGY CORP NEW | $896,000 | 1.07% | 280,000 | Common | SOLE |
| G17977110 | BUR | BURFORD CAP LTD | $727,260 | 0.87% | 51,000 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $696,260 | 0.83% | 62,000 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $669,320 | 0.80% | 116,000 | Common | SOLE |
| 52634L108 | LNSR | LENSAR INC | $658,500 | 0.79% | 50,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $640,900 | 0.76% | 5,000 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $619,455 | 0.74% | 58,605 | Common | SOLE |
| 78501P203 | SWKH | SWK HLDGS CORP | $604,340 | 0.72% | 41,000 | Common | SOLE |
| 78574H104 | SOC | SABLE OFFSHORE CORP | $549,500 | 0.66% | 25,000 | Common | SOLE |
| 23292B104 | HEPS | D MARKET ELECTR SVCS & TRADI | $540,000 | 0.64% | 200,000 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $539,010 | 0.64% | 67,800 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $521,250 | 0.62% | 75,000 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $493,856 | 0.59% | 355,292 | Common | SOLE |
| 82981J851 | SITC | SITE CTRS CORP | $452,411 | 0.54% | 40,001 | Common | SOLE |
| G8807B106 | TBPH | THERAVANCE BIOPHARMA INC | $372,031 | 0.44% | 33,729 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $332,332 | 0.40% | 905,289 | Common | SOLE |
| G6301B127 | MLACR | MOUNTAIN LAKE ACQUISITION CO | $307,800 | 0.37% | 30,000 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $306,042 | 0.37% | 153,790 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $289,000 | 0.34% | 170,000 | Common | SOLE |
| G4863A108 | BRSL | INTERNATIONAL GAME TECHNOLOG | $268,770 | 0.32% | 17,000 | Common | SOLE |
| 487836108 | K | KELLANOVA | $238,590 | 0.28% | 3,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $215,900 | 0.26% | 5,000 | CALL | SOLE |
| N97284108 | NBIS | NEBIUS GROUP N.V. | $215,787 | 0.26% | 3,900 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $212,400 | 0.25% | 20,000 | Common | SOLE |
| 96758W101 | WOW | WIDEOPENWEST INC | $203,000 | 0.24% | 50,000 | CALL | SOLE |
| 586001109 | 75Z | SOHO HOUSE & CO INC | $202,860 | 0.24% | 27,600 | Common | SOLE |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $190,800 | 0.23% | 53,000 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $172,426 | 0.21% | 41,851 | Common | SOLE |
| G33033104 | KDK | ARES ACQUISITION CORP II | $135,054 | 0.16% | 11,920 | Common | SOLE |
| G4R103107 | — | GSR III ACQUISITION CORP | $118,690 | 0.14% | 11,000 | Common | SOLE |
| 88338H704 | TQ80 | THERATECHNOLOGIES INC | $118,000 | 0.14% | 50,000 | Common | SOLE |
| 89621C105 | TMQ | TRILOGY METALS INC NEW | $117,450 | 0.14% | 87,000 | Common | SOLE |
| G63365103 | MURA | MURAL ONCOLOGY PUB LTD CO | $114,887 | 0.14% | 46,513 | Common | SOLE |
| G81354105 | SBXD | SILVERBOX CORP IV | $109,600 | 0.13% | 10,000 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $71,466 | 0.09% | 29,902 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $69,855 | 0.08% | 60,220 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $68,900 | 0.08% | 65,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $48,230 | 0.06% | 13,000 | Common | SOLE |
| 00974H104 | — | AKOYA BIOSCIENCES INC | $42,946 | 0.05% | 33,035 | Common | SOLE |
| 92854T100 | — | VIVID SEATS INC | $42,250 | 0.05% | 25,000 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $38,850 | 0.05% | 35,000 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $35,736 | 0.04% | 27,073 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $32,670 | 0.04% | 27,000 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $25,350 | 0.03% | 13,000 | Common | SOLE |
| 55279B301 | LITS | MEI PHARMA INC | $24,700 | 0.03% | 10,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $24,320 | 0.03% | 16,000 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $22,050 | 0.03% | 21,000 | Common | SOLE |
| 81578P106 | SEER | SEER INC | $21,400 | 0.03% | 10,000 | Common | SOLE |
| 66987P409 | — | NOVABAY PHARMACEUTICALS INC | $19,262 | 0.02% | 33,210 | Common | SOLE |
| 87166L209 | SYBX | SYNLOGIC INC | $17,268 | 0.02% | 13,597 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.